1. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX scientific and standardization committee of the international society for thrombosis and haemostasis;Morfini;Thromb. Haemost.,1991
2. M. Lee, M. Morfini, S. Schulman, J. Ingerslev, and the Factor VIII/Factor IX Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, https://c.ymcdn.com/sites/www.isth.org/resource/group/d4a6f49a-f4ec-450f-9e0f-7be9f0c2ab2e/officialcommunications/fviiipharmaco.pdf?hhSearchTerms=%22morfini%22 (Accessed on July 29, 2020).
3. Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients;Castaman;Haemophilia,2019
4. Non-Compartment and Compartmental Pharmacokinetics, Efficacy, and Safety of Kedrion FIX concentrate;Castaman;Eur. J. Pharm. Sci.,2020